This article, published in Advances in Pulmonary Hypertension, refers to a round table covened to discuss the 2022 joint ERS/ESC guidelines on pulmonary hypertension. The round table was attended by Dr Thenappan Thenappan, University of Minnesota, Minneapolis; Dr Marc Humbert, Université Paris-Saclay, Paris; Dr Vallerie McLaughlin, University of Michigan, Ann Arbor; Dr Hilary DuBrock, Mayo Clinic, Rochester; and Dr Charles D. Burger, Mayo Clinic, Jacksonville, Florida.
The article is very interesting on a general level as it delves into the innovations brought on by this new edition of the guidelines; we would like to highlight the instances in which patients and their role in the task force which developed the guidelines are mentioned.
Prof. Marc Humbert: “There is a very important thing in the guidelines. We included patients in the guideline taskforce, and they are authors of the guidelines. I think that’s something really important for the discussion today.”
Dr. Hllary DuBrock: “I’d like to echo the comment that it’s really important that patients were included in these guidelines, and I think it’s a good standard to set moving forward of incorporating patients and patient-reported outcomes in both guideline development and clinical decision making”.
“PH Roundtable: Pros and Cons of the 2022 ERS/ESC Guidelines: Practicality vs Real World View”, Advances in Pulmonary Hypertension (2023) 22 (1): 71–78, April 13, 2023, https://doi.org/10.21693/1933-088X-22.1.71